Cargando…

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions

INTRODUCTION: There are increasing concerns regarding the inappropriate use of medicines with expenditure continuing to grow driven by increasing sales in oncology and orphan diseases, enhanced by their emotive nature. As a result, even high income countries are struggling to fund new premium priced...

Descripción completa

Detalles Bibliográficos
Autores principales: Gad, Mohamed, Salem, Ahmed, Oortwijn, Wija, Hill, Ruaraidh, Godman, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063972/
https://www.ncbi.nlm.nih.gov/pubmed/32194401
http://dx.doi.org/10.3389/fphar.2020.00144
_version_ 1783504792865210368
author Gad, Mohamed
Salem, Ahmed
Oortwijn, Wija
Hill, Ruaraidh
Godman, Brian
author_facet Gad, Mohamed
Salem, Ahmed
Oortwijn, Wija
Hill, Ruaraidh
Godman, Brian
author_sort Gad, Mohamed
collection PubMed
description INTRODUCTION: There are increasing concerns regarding the inappropriate use of medicines with expenditure continuing to grow driven by increasing sales in oncology and orphan diseases, enhanced by their emotive nature. As a result, even high income countries are struggling to fund new premium priced medicines. These concerns have resulted in initiatives to better manage the entry of new medicines and enhance the rational use of medicines (RUM). However, there is a need to ascertain the current situation. We sought to address this by developing the Current Obstacles for Rationalizing Use of Medicines in Europe (CORUM) mapping tool to qualitatively investigate the current situation and provide analysis of current views on RUM and interventions among key European payers and their advisers. The findings will be used to provide future guidance. METHODOLOGY: Descriptive study exploring and identifying perceived gaps to achieving optimal RUM. The CORUM tool was based on the WHO 12 key interventions to promote RUM. RESULTS: 62 participants took part with most respondents believing their country could improve RUM capacity. This included educational initiatives on the use of clinical guidelines (90%) and the inclusion of problem-based pharmacotherapy in undergraduate curricula and for Continued Professional Development. Key challenges included a lack of regular updates of guidelines, exacerbated by limited funding and a lack of follow-up to monitor adherence to agreed guidelines. RUM could also be enhanced by the development of regional formularies as well as implementing Drug and Therapeutic Committees where these are currently limited. There also needs to be greater co-ordination between RUM and Health Technology Assessment activities, with countries learning from each other. CONCLUSION: There is an urgent need to improve RUM through improved educational and other activities among European countries, with countries learning from each other. This will involve addressing current challenges and we will be following this up.
format Online
Article
Text
id pubmed-7063972
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70639722020-03-19 Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions Gad, Mohamed Salem, Ahmed Oortwijn, Wija Hill, Ruaraidh Godman, Brian Front Pharmacol Pharmacology INTRODUCTION: There are increasing concerns regarding the inappropriate use of medicines with expenditure continuing to grow driven by increasing sales in oncology and orphan diseases, enhanced by their emotive nature. As a result, even high income countries are struggling to fund new premium priced medicines. These concerns have resulted in initiatives to better manage the entry of new medicines and enhance the rational use of medicines (RUM). However, there is a need to ascertain the current situation. We sought to address this by developing the Current Obstacles for Rationalizing Use of Medicines in Europe (CORUM) mapping tool to qualitatively investigate the current situation and provide analysis of current views on RUM and interventions among key European payers and their advisers. The findings will be used to provide future guidance. METHODOLOGY: Descriptive study exploring and identifying perceived gaps to achieving optimal RUM. The CORUM tool was based on the WHO 12 key interventions to promote RUM. RESULTS: 62 participants took part with most respondents believing their country could improve RUM capacity. This included educational initiatives on the use of clinical guidelines (90%) and the inclusion of problem-based pharmacotherapy in undergraduate curricula and for Continued Professional Development. Key challenges included a lack of regular updates of guidelines, exacerbated by limited funding and a lack of follow-up to monitor adherence to agreed guidelines. RUM could also be enhanced by the development of regional formularies as well as implementing Drug and Therapeutic Committees where these are currently limited. There also needs to be greater co-ordination between RUM and Health Technology Assessment activities, with countries learning from each other. CONCLUSION: There is an urgent need to improve RUM through improved educational and other activities among European countries, with countries learning from each other. This will involve addressing current challenges and we will be following this up. Frontiers Media S.A. 2020-03-03 /pmc/articles/PMC7063972/ /pubmed/32194401 http://dx.doi.org/10.3389/fphar.2020.00144 Text en Copyright © 2020 Gad, Salem, Oortwijn, Hill and Godman http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Gad, Mohamed
Salem, Ahmed
Oortwijn, Wija
Hill, Ruaraidh
Godman, Brian
Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
title Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
title_full Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
title_fullStr Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
title_full_unstemmed Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
title_short Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
title_sort mapping of current obstacles for rationalizing use of medicines (corum) in europe: current situation and potential solutions
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063972/
https://www.ncbi.nlm.nih.gov/pubmed/32194401
http://dx.doi.org/10.3389/fphar.2020.00144
work_keys_str_mv AT gadmohamed mappingofcurrentobstaclesforrationalizinguseofmedicinescorumineuropecurrentsituationandpotentialsolutions
AT salemahmed mappingofcurrentobstaclesforrationalizinguseofmedicinescorumineuropecurrentsituationandpotentialsolutions
AT oortwijnwija mappingofcurrentobstaclesforrationalizinguseofmedicinescorumineuropecurrentsituationandpotentialsolutions
AT hillruaraidh mappingofcurrentobstaclesforrationalizinguseofmedicinescorumineuropecurrentsituationandpotentialsolutions
AT godmanbrian mappingofcurrentobstaclesforrationalizinguseofmedicinescorumineuropecurrentsituationandpotentialsolutions